DXC-TECHNOLOGY
16.3.2022 08:02:05 CET | Business Wire | Press release
DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, has been awarded a four-year contract by PreZero Group, a leading Spanish environmental services provider, which is part of Schwarz Group, Europe’s largest retailer. DXC will help PreZero to transform its IT systems, enabling it to develop innovative approaches to waste recycling for over 15 million citizens across Spain and Portugal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005154/en/
DXC will work with PreZero to build a modern digital platform to accelerate the development of innovative and sustainable waste recycling methods, helping them with their mission to protect the environment and create a sustainable value chain using an efficient, digitized, circular economy recycling system.
PreZero is the waste and recycling management expert for the Schwarz Group, the company behind Lidl, one of Europe’s leading supermarket groups. Using a variety of environmental innovations, PreZero has a successful track record in converting waste into new products, directly contributing to the circular economy. For example, PreZero is one of the pioneers in using the larvae of black soldier flies to process food waste into high-protein animal feed. Elsewhere, PreZero is using AI-powered waste sorting technology and developing sustainable packaging solutions using plant fibers as an alternative to wood pulp in paper and cardboard packaging.
DXC will help PreZero to modernize and reconfigure the legacy IT estate that it inherited through the acquisition of Ferrovial's environmental business in Spain and Portugal. By moving its operations to the cloud and introducing the latest automation and security technologies, PreZero will benefit from improved business continuity, decreased risk and increased flexibility to support its growth. DXC will also support the PreZero’s 17,000 employees with modern workplace services, helping to improve workforce productivity and collaboration.
“With DXC’s decades of IT industry expertise, it is a trusted partner for us in our journey to the cloud and next chapter of growth,” said Francisco Gimeno, Director of Digital Transformation at PreZero Spain. “We are counting on them to implement, advance and automate our IT estate and enable us to drive innovation in the waste management industry.”
“We are delighted to be selected as the trusted technology partner for PreZero Spain and are excited to support their goal of building a more sustainable future,” said Alfonso García Muriel, Business Director of DXC Technology Spain. “With this new agreement, we will build on our ten-year cooperation with PreZero Spain’s predecessor, Ferrovial Services (Cespa). We have a deep understanding of the complexities of merging the IT infrastructures of two companies and we will work closely with PreZero to build a new, modern IT foundation that will support their ambitious business and environmental goals.”
About PreZero in Spain and Portugal
With over 17,000 employees and a presence in more than 600 municipalities, PreZero in Spain and Portugal provides environmental services to more than 15 million citizens and manages more than 140 treatment facilities: eco-parks, composting plants, industrial plants, circular economy plants, transfer centers and controlled deposits.
The company provides waste disposal, sorting, processing and recycling services, combining all the expertise along the value chain under one roof. PreZero strives to be an innovation driver in the industry with the goal of creating a world in which resources are no longer wasted thanks to closed loops. Zero waste, 100 percent reusable material.
The company is part of the Schwarz Group, one of the leading food retail companies in Germany and Europe, including Lidl and Kaufland. www.prezero.es
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services across the Enterprise Technology Stack to drive new levels of performance, competitiveness, and customer experience. Learn more about how we deliver excellence for our customers and colleagues at DXC.com .
Forward Looking Statement
All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by the coronavirus disease 2019 pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate. For a written description of these factors, see the section titled “Risk Factors” in DXC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, and any updating information in subsequent SEC filings, including DXC’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2021.
No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements, which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005154/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release
The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
